Histopathology, the study of disease-related tissue changes, benefits greatly from genetic research. By identifying genetic markers associated with specific diseases, pathologists can improve diagnostic accuracy and prognosis. For example, the detection of BRCA1/2 mutations in breast cancer patients can inform risk assessment and preventive measures. Moreover, the study of genetic mutations in infectious diseases can reveal pathogen-host interactions at the tissue level, aiding in the development of effective treatments and vaccines.
